GLP-3RT is an investigational triple-agonist peptide designed to simultaneously activate GLP-1, GIP, and glucagon receptors. This multi-receptor activity places it in a new class of metabolic research compounds aimed at studying energy regulation, body-weight modulation, and glucose homeostasis.
Early scientific literature suggests that GLP-3RT may produce robust reductions in body weight, enhance insulin sensitivity, and influence lipid metabolism more significantly than single-pathway agonists. Its glucagon-receptor engagement also makes it a candidate for investigating thermogenesis, fat oxidation, and hepatic metabolic pathways.
